Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis

Clinical and Experimental Rheumatology

Volumn 29, Issue 1 SUPPL. 64, 2011, Pages

  Sumida, Keiichi ^a   Ubara, Y ^a   Takemoto, F ^a   Takaichi, K ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BUCILLAMINE; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FLUOROMETHOLONE; INFLIXIMAB; METHOTREXATE; RECOMBINANT TUMOR NECROSIS FACTOR; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORNEA ULCER; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERITIS; SYSTEMIC RHEUMATOID VASCULITIS; SYSTEMIC VASCULITIS; TREATMENT RESPONSE; ABSENCE OF SIDE EFFECTS; ARTHRITIS; DRUG SAFETY; JAPANESE (PEOPLE); MULTIDRUG RESISTANCE; REMISSION; RHEUMATOID VASCULITIS;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; RECEPTORS, INTERLEUKIN-6; REMISSION INDUCTION; RHEUMATOID VASCULITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTORS;

EID: 79960393209     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. GENTA MS, GENTA RM, GABAY C: Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 2006; 36: 88-98.
2. PUÉCHAL X, MICELI-RICHARD C, MEJJAD O et al.: Club Rhumatismes et Inflammation (CRI). Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 880-4.
3. DICK AD, DUNCAN L, HALE G, WALDMANN H, ISAACS J: Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun 1998; 11: 255-64.
4. WAKEFIELD D, LLOYD A: The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992; 4: 1-5.
5. PRADA J, B NOELLE, H BAATZ, HARTMANN C, PLEYER U: Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol 2003; 87: 548-50.
6. BOTSIOS C, SFRISO P, OSTUNI PA, TODESCO S, PUNZI L: Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases. Rheumatology 2007; 46: 1042-3.
7. ASSMANN G, PFREUNDSCHUH M, VOSWINKEL J: Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers. Clin Exp Rheumatol 2010; 28 (Suppl. 57): S81-S83.